99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

Who May Qualify: - Voluntary subjects, patients or their legal representatives sign willing to sign a consent form; - Volunteers are of any gender and aged between 18 and 75 years old, including the cut-off value; - Other imaging methods found tumor occupying; - Patients with pre-treatment tumors for whom surgery or biopsy may be performed to obtain final pathological results. - Kidney glomerular filtration rate(GFR)\>50 ml/min, effective renal plasma flow(ERPF)\>280 ml/min, platelet count (PLT) \>75 000/μL, white blood cell (WBC) \>3000/μL, alanine aminotransferase ALT, aspartate aminotransferase AST less than 3 times the normal value. Who Should NOT Join This Trial: - People who have a history of allergy to similar drugs , allergic constitution or are currently suffering from allergic diseases; - Is conducting clinical research on other drugs, or has participated in clinical research on any drugs (excluding vitamins and minerals); - Have other clinical problems that are difficult to control (such as hepatitis C virus infection or active hepatitis B, or other serious chronic infections and serious mental, neurological, cardiovascular, respiratory and other diseases); - Obvious abnormal liver and kidney function, GFR less than 50 ml/min; - Tumor load is greater than 50%, or there is obvious spinal cord compression; - The expected survival period is less than half a year; Chemotherapy was performed within 6 months. - Have severe acute concomitant diseases or serious refractory mental disorders; - Pregnant and lactating women (where pregnancy is defined as a positive urine pregnancy study); - Patients whose physical condition is not suitable for radiological examination; - Other situations deemed inappropriate by the investigator to participate in the trial. Always talk to your doctor about whether this trial is right for you.